EGFR and neutropenia: M-TOR invited more thrombocytopenia events than EGFR (OR = 5.37, 95% CrI = 1.11–37.71) and was associated with higher risk of neutropenia compared to placebo and EGFR (OR = 12.81, 95% CrI = 1.23–432.68; OR = 13.46, 95% CrI = 1.13–487.85, respectively).